Panagora Asset Management Inc. Has $28.94 Million Stake in Humana Inc. $HUM

Panagora Asset Management Inc. boosted its holdings in Humana Inc. (NYSE:HUM) by 15,093.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 118,359 shares of the insurance provider’s stock after acquiring an additional 117,580 shares during the quarter. Panagora Asset Management Inc.’s holdings in Humana were worth $28,936,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Cary Street Partners Investment Advisory LLC raised its position in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 46 shares during the last quarter. Elevation Point Wealth Partners LLC bought a new position in shares of Humana in the 2nd quarter worth $32,000. Zions Bancorporation National Association UT acquired a new stake in shares of Humana during the first quarter worth $37,000. AlphaCore Capital LLC bought a new stake in Humana in the second quarter valued at about $39,000. Finally, CVA Family Office LLC increased its holdings in Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after purchasing an additional 85 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Shares of HUM stock opened at $242.65 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The company’s 50 day moving average price is $262.88 and its two-hundred day moving average price is $257.15. The company has a market capitalization of $29.18 billion, a P/E ratio of 18.62, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.16 earnings per share. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Friday, December 26th. Humana’s payout ratio is 33.18%.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a report on Wednesday, October 8th. Barclays reduced their price objective on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 25th. Truist Financial decreased their price objective on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Wells Fargo & Company increased their target price on shares of Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Finally, Sanford C. Bernstein lifted their price target on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $295.94.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.